Polyethylene glycol-stabilized cationic liposome encapsulating glucosamine sulfate: A promising nanoformulation for osteoarthritis therapy
Source abstract
Abstract
Osteoarthritis (OA) is a common orthopedic chronic disease, and the use of nanomaterials as carriers is an effective way to realize slow and controlled release therapy for OA drugs. In this study, we synthesized a polyethylene glycol-stabilized bilayer-decorated cationic liposome (CLis) as a drug delivery system for delivering glucosamine sulfate (GS) drug to achieve the treatment of OA in rats. The CLis encapsulated with GS drug (GS-CLis) was prepared by a reverse evaporation method, and its physical properties, encapsulation rate, and drug release performance were evaluated. The biological properties of GS-CLis were evaluated in vitro. The therapeutic effect of GS-CLis on osteoarthritis was evaluated in vivo, and the in vivo biosafety of the drug was assessed by hematology, blood biochemistry, and hematoxylin-eosin staining. GS-CLis had a particle size of (236.28 ± 4.76) nm, a potential of (27.35 ± 4.86) mv, and a spherical shape. The encapsulation rate was (96.18 ± 5.77)% and the drug-loading capacity was (9.61 ± 0.28)%, which provided a good slow drug release. GS-CLis has low cytotoxicity, low hemolysis rate, and good biocompatibility. GS-CLis can more effectively alleviate joint surface damage and inhibit the expression of inflammatory factors, and has no significant effect on the body weight of rats, with good biological safety. In this study, we successfully synthesized novel GS-CLis for the treatment of OA, which improved the retention time and therapeutic effect of GS in OA and provided a research basis for its development as an OA nanoformulation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedics 2, Shanghai Jing’an District Zhabei Central Hospital 1 , 200073 Shanghai, China
Department of Anaesthesia, Shanghai Jing’an District Zhabei Central Hospital 2 , 200073 Shanghai, China
References (51)
Show source-provided references
1. Inflammaging and osteoarthritis10.1007/s12016-022-08941-1 ↗
2. Causal relationships between osteoarthritis and senile central nerve system dysfunction: A bidirectional two-sample mendelian randomization study10.3389/fnagi.2021.793023 ↗
3. Osteoarthritis year in review 2021: Epidemiology and therapy10.1016/j.joca.2021.10.003 ↗
4. Osteoarthritis: Pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
5. Knee replacement10.1016/s0140-6736(18)32344-4 ↗
6. Intraarticular injection of bone marrow-derived mesenchymal stem cells enhances regeneration in knee osteoarthritis10.1007/s00167-020-05859-z ↗
7. A review of the efficacy of intraarticular hip injection for patients with hip osteoarthritis: To inject or not to inject in hip osteoarthritis?10.52312/jdrs.2022.402 ↗
8. Nucleic acid nanomaterials-based therapy for osteoarthritis: Progress and prospects10.2174/1389200224666230202155414 ↗
9. Development of nanomaterials to target articular cartilage for osteoarthritis therapy10.3389/fmolb.2022.900344 ↗
10. Design of liposomes as drug delivery system for therapeutic applications10.1016/j.ijpharm.2021.120571 ↗
11. Tuning liposome stability in biological environments and intracellular drug release kinetics10.3390/biom13010059 ↗
12. Development of the observation of membrane fusion with label-free liposomes by calcium imaging10.1016/j.bbrep.2023.101483 ↗
13. Charge conversion polymer-liposome complexes to overcome the limitations of cationic liposomes in mitochondrial-targeting drug delivery10.3390/ijms23063080 ↗
14. Membrane fusion with cationic liposomes: Effects of target membrane lipid composition10.1021/bi961173x ↗
15. Effect of doxorubicin release rate from polyethylene glycol-modified liposome on anti-tumor activity in B16-BL6 tumor-bearing mice10.1016/j.xphs.2021.11.020 ↗
16. Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study10.1016/j.jconrel.2021.03.014 ↗
17. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?10.1016/j.maturitas.2014.04.015 ↗
18. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis10.1056/nejmoa052771 ↗
19. Construction and evaluation in vitro and in vivo of tedizolid phosphate loaded cationic liposomes10.1080/08982104.2017.1380665 ↗
20. One-step preparation of chitosan-coated cationic liposomes by an improved supercritical reverse-phase evaporation method10.1021/la051662a ↗
21. Construction of multi-program responsive vitamin E succinate-chitosan-histidine nanocarrier and its response strategy in tumor therapy10.1016/j.ijbiomac.2023.125678 ↗
22. Research on the inhibitory effect of doxorubicin-loaded liposomes targeting GFAP for glioma cells10.2174/0118715206265311231030102307 ↗
23. Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration10.1055/a-0586-8406 ↗
24. Drug encapsulated lipid-polymeric nanohybrid as a chemo-therapeutic platform of cancer10.7150/ntno.81173 ↗
25. The characteristics and biological activity enhancements of melatonin encapsulations for skin care product applications10.1016/j.ijpx.2023.100217 ↗
26. Application and efficacy of melatonin elastic liposomes in photoaging mice10.1155/2022/7135125 ↗
27. Influence of type and proportion of lyoprotectants on lyophilized ginsenoside Rg3 liposomes10.1111/jphp.12489 ↗
28. Biomaterials for articular cartilage tissue engineering: Learning from biology10.1016/j.actbio.2017.11.021 ↗
29. Etoricoxib-loaded bio-adhesive hybridized polylactic acid-based nanoparticles as an intra-articular injection for the treatment of osteoarthritis10.1016/j.ijpharm.2020.119081 ↗
30. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis10.1016/j.actbio.2019.03.010 ↗
31. Intra-articular nanodrug delivery strategies for treating osteoarthritis10.1016/j.drudis.2022.103482 ↗
32. Articular cartilage- and synoviocyte-binding poly(ethylene glycol) nanocomposite microgels as intra-articular drug delivery vehicles for the treatment of osteoarthritis10.1021/acsbiomaterials.0c00960 ↗
33. A lipidomic study of phospholipid classes and species in human synovial fluid10.1002/art.38053 ↗
34. Phospholipid composition of articular cartilage boundary lubricant10.1016/s0736-0266(00)00064-4 ↗
35. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis10.1016/j.ejps.2018.09.009 ↗
36. Steady augmentation of anti-osteoarthritic actions of rapamycin by liposome-encapsulation in collaboration with low-intensity pulsed ultrasound10.2147/ijn.s252223 ↗
37. Glucosamine sulphate-loaded distearoyl phosphocholine liposomes for osteoarthritis treatment: Combination of sustained drug release and improved lubrication10.1039/c9bm00201d ↗
38. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles10.1016/j.addr.2021.113974 ↗
39. Single-vesicle assays using liposomes and cell-derived vesicles: From modeling complex membrane processes to synthetic biology and biomedical applications10.1021/acs.chemrev.7b00777 ↗
40. Preparation of uniform nano liposomes using focused ultrasonic technology10.3390/nano13192618 ↗
41. Surface modification of liposomes using folic acid10.1007/978-1-0716-2954-3_16 ↗
42. Comparison of chemical-induced temporomandibular osteoarthritis rat models (monosodium iodoacetate versus collagenase type II) for the study of prolonged drug delivery systems10.1371/journal.pone.0281135 ↗
43. Kartogenin potentially protects temporomandibular joints from collagenase-induced osteoarthritis via core binding factor β and runt-related transcription factor 1 binding—A rat model study10.1016/j.jds.2023.03.002 ↗
44. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse10.1016/j.joca.2007.03.006 ↗
45. Anterior cruciate ligament reconstruction with concomitant meniscal surgery: A systematic review and meta-analysis of outcomes10.1007/s00167-019-05389-3 ↗
46. The genesis of pain in osteoarthritis: Inflammation as a mediator of osteoarthritis pain10.1016/j.cger.2021.11.013 ↗
47. Evaluation of the anti-inflammatory activity of fisetin-loaded nanoparticles in an in vitro model of osteoarthritis10.1038/s41598-023-42844-1 ↗
48. Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response10.1016/j.jconrel.2011.10.008 ↗
49. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery10.1016/j.jpba.2020.113642 ↗
50. Recent advances and perspectives in liposomes for cutaneous drug delivery10.2174/0929867324666171009120154 ↗
51. Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications10.1039/c9tb02470k ↗